Fibroblast growth factor 21 is considered a potential diagnostic marker of NAFLD since its concentrations are higher in NAFLD patients and correlate with hepatic fat content [180,181,182]. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.